Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification

NCT03832179 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Macular Edema
Cataract

Interventions

DRUG: Bevacizumab
DRUG: Ranibizumab
DRUG: Aflibercept
DRUG: Ozurdex

Sponsor

Bay Area Retina Associates

Collaborators

[object Object]